Nano-X, InMode, Teva among notable Israel-based healthcare decliners_老虎社区_美港股上老虎

Nano-X, InMode, Teva among notable Israel-based healthcare decliners

seekingalpha2023-10-10

Healthcare companies headquartered in Israel were trading lower in the U.S. on Monday after the country declared war on the Hamas organization, sparking a large-scale armed conflict in the Palestinian...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2374454025?lang=zh_CN&edition=full","thumbnail":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1713753449/image_1713753449.jpg","is_english":true,"pubTime":"2023-10-10 01:00","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2374454025","market":"us","top_or_hot":-1,"title":"Nano-X, InMode, Teva among notable Israel-based healthcare decliners","media":"seekingalpha","content":"<div>\n<p>Healthcare companies headquartered in Israel were trading lower in the U.S. on Monday after the country declared war on the Hamas organization, sparking a large-scale armed conflict in the Palestinian...</p>\n\n<a href=\"https://seekingalpha.com/news/4019178-nano-x-inmode-teva-among-notable-israel-based-healthcare-decliners\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nano-X, InMode, Teva among notable Israel-based healthcare decliners</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNano-X, InMode, Teva among notable Israel-based healthcare decliners\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-10-10 01:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4019178-nano-x-inmode-teva-among-notable-israel-based-healthcare-decliners><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Healthcare companies headquartered in Israel were trading lower in the U.S. on Monday after the country declared war on the Hamas organization, sparking a large-scale armed conflict in the Palestinian...</p>\n\n<a href=\"https://seekingalpha.com/news/4019178-nano-x-inmode-teva-among-notable-israel-based-healthcare-decliners\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"GMDA","symbol_name":"Gamida Cell Ltd.","start_time":0,"source_url":"https://seekingalpha.com/news/4019178-nano-x-inmode-teva-among-notable-israel-based-healthcare-decliners","article_id":"2374454025","we_media_id":null,"thumbnails":["https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1713753449/image_1713753449.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2374454025","pubTimestamp":1696870803,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Healthcare companies headquartered in Israel were trading lower in the U.S. on Monday after the country declared war on the Hamas organization, sparking a large-scale armed conflict in the Palestinian","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"GMDA":"Gamida Cell Ltd.","TEVA":"梯瓦制药","ICCM":"IceCure Medical Ltd.","BK4584":"避孕概念","PYPD":"PolyPid Ltd.","BK4585":"ETF&股票定投概念","KMDA":"Kamada Ltd.","BK4139":"生物科技","CGEN":"Compugen医疗","BK4007":"制药","BK4566":"资本集团","BWAY":"Brainsway Ltd.","NNOX":"Nano-X Imaging Ltd.","CHEK":"Check Cap Ltd","CANF":"Can-Fite Biopharma Ltd","INMD":"InMode Ltd.","MDWD":"MediWound Ltd.","BK4082":"医疗保健设备","ENLV":"Enlivex Therapeutics Ltd.","BK4557":"大麻股","INCR":"Intercure Ltd","BK4121":"生命科学工具和服务","BK4559":"巴菲特持仓","BK4588":"碎股"},"translate_title":"Nano-X、InMode、Teva是以色列著名的医疗保健公司中的佼佼者","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CGEN":1,"VBLT":1,"TEVA":1,"PYPD":1,"NNOX":1,"MDWD":1,"KMDA":1,"INMD":1,"INCR":1,"ICCM":1,"GMDA":1,"ENLV":1,"CHEK":1,"CANF":1,"BWAY":1},"content_text":"Healthcare companies headquartered in Israel were trading lower in the U.S. on Monday after the country declared war on the Hamas organization, sparking a large-scale armed conflict in the Palestinian territory of Gaza. Notable decliners include Tel Aviv-based generic drugmaker Teva Pharmaceutical Industries (NYSE:TEVA) and MedTech companies Nano-X Imaging (NASDAQ:NNOX) and InMode (NASDAQ:INMD).  Other Israel-based biopharma companies to fall include Kamada (KMDA), InterCure (INCR), Can-Fite BioPharma (CANF), Vascular Biogenics (VBLT), Gamida Cell (GMDA), Enlivex Therapeutics (ENLV), and Protalix BioTherapeutics (NYSE:PLX). Israel-based MedTech companies IceCure Medical (ICCM), BrainsWay (BWAY), Check-Cap (CHEK), and life sciences company Compugen (CGEN) were also among the notable decliners. Meanwhile, Israeli wound care company MediWound (MDWD) said Monday it is ready to meet the sudden demand for its NexoBrid burn solution in the wake of the conflict. “Hospitals and military forces have urgently requested NexoBrid supplies. To address this critical need, MediWound has deployed all its available NexoBrid inventory to aid the substantial number of burn victims,” MDWD said.  Notably, PolyPid (PYPD), an Israeli-based nano-cap pharma company, is trading higher after announcing an upcoming Phase 3 readout on its lead asset, D-PLEX100, at a medical conference later this month.    More on InMode, Nano-X, etc.  Full Of Potential Red Flags: Breaking Down Nano-X Imaging Nano-X Imaging: Cash Burn Makes It A Hold InMode: Bullish Support Failed To Materialize War between Israel and Hamas pushes U.S.-traded Israeli stocks lower Teva, Sanofi in pact for bowel disease therapy","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":1,"favoriteSize":1,"likeStatus":false,"favoriteStatus":false}}